patents

  • Read more: Innovation Gaps on Life Science Frontiers
    Article

    Innovation Gaps on Life Science Frontiers

    By Timo Minssen Join us in wonderful Copenhagen at our CeBIL Kick-Off Conference: ”Innovation Gaps on Life Science Frontiers? From Antimicrobial Resistance & the Bad Bugs to New Uses, AI & the Black Box”. The  Conference marks the start of the Novo Nordisk Foundation’s Collaborative Research Programme in Biomedical Innovation Law which is carried out…

  • Read more: Errors in Patent Grants: More Common in Medical Patents
    Article

    Errors in Patent Grants: More Common in Medical Patents

    By James Love Recently I have become interested in the frequency of a “certificate of correction” on a granted patent, after two efforts to establish federal rights in patents granted. The first case involved the University of Pennsylvania.  We had identified five patents on CAR T technologies granted to five inventors from the University of…

  • Read more: Innovation and the Firm: Vertical Integration in Patent-Intensive Industries – Seminar 9/8 at the University of Copenhagen
    Article

    Innovation and the Firm: Vertical Integration in Patent-Intensive Industries – Seminar 9/8 at the University of Copenhagen

    Looking forward to hear Professor Peter Lee’s (UC Davis) talk on “Innovation and the Firm: Vertical Integration in Patent-Intensive Industries” at the University of Copenhagen on Friday, Friday, September 8th 2017 from 10:00 – 12:00. If you are interested to join, please register here. Abstract of Professor Lee’s talk: Recent scholarship has highlighted the prevalence of…

  • Read more: Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension
    Article

    Patenting Bioprinting Technologies in the US and Europe – The Fifth Element in the Third Dimension

    By Timo Minssen I am happy to announce the publication of our new working paper on  “Patenting Bioprinting Technologies in the US and Europe – The 5th element in the 3rd dimension.” The paper, which has  been co-authored by Marc Mimler, starts out by describing the state of the art and by examining what sorts of bioprinting inventions…

  • Read more: Separating sheep from goats- a European view on the patent eligibility of biomedical diagnostic methods
    Article

    Separating sheep from goats- a European view on the patent eligibility of biomedical diagnostic methods

    By Timo Minssen New publication on the patentability of biomedical diagnostics out: Abstract: This brief comment complements Dan Burk’s excellent paper ( Dolly and Alice, J Law and the Biosciences (2015), 1–21, doi:10.1093/jlb/lsv042 ) by providing a very brief summary of the European approach regarding patents on medical diagnostic methods. This serves as the basis for…

  • Read more: Amicus brief in Sequenom v. Ariosa: Why the U.S. Supreme Court should grant the petition for a writ of certiorari
    Article

    Amicus brief in Sequenom v. Ariosa: Why the U.S. Supreme Court should grant the petition for a writ of certiorari

    By Timo Minssen I am happy to announce that on April 20th the New York attorney Robert M. Schwartz and I have filed an amicus brief at the US Supreme Court with Berkeley-based Andrew J. Dhuey as Counsel of Record. The brief, which was signed by 10 prominent  European and Australian Law Professors as amici curiae, adds a…